Clinical value of the platelet and inflammatory factor activation in vascular endothelial injury in essential

Zheng-Wei Jian1, Xiao-Ming Zhang1, Guan-Shen Huang2

  • 1Department of Cardiovascular Medicine, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital). Dongguan, Guangdong, China.

Insights

Platelet and inflammatory factor activation are linked to vascular endothelial injury in hypertension. These markers effectively indicate endothelial dysfunction, highlighting their clinical value in managing hypertension complications.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Immunology

Background:

  • Hypertension is a major risk factor for cardiovascular diseases, often associated with endothelial dysfunction.
  • Vascular endothelial injury plays a critical role in the pathogenesis and progression of hypertension-related complications.
  • Platelet activation and inflammatory responses are implicated in vascular damage, but their specific role in hypertension needs further elucidation.

Purpose of the Study:

  • To investigate the clinical significance of platelet activation markers and inflammatory factors in assessing vascular endothelial injury among hypertensive patients.
  • To determine the correlation between platelet activation, inflammatory markers, and endothelial function in hypertension.
  • To identify key indicators of platelet and inflammatory activation that predict endothelial dysfunction in hypertension.

Main Methods:

  • Recruited 120 hypertension patients and 60 healthy controls.
  • Measured mean platelet volume (MPV), platelet distribution width (PDW), platelet hematocrit (PCT), IL-6, IL-8, TNF-α, and reactive hyperemia index (RHI).
  • Employed regression and Spearman correlation analyses to assess relationships and risk factors.

Main Results:

  • Hypertension patients showed elevated MPV, PDW, PCT, IL-6, IL-8, TNF-α, and reduced RHI compared to controls.
  • Significant negative correlations were observed between MPV, PDW, PCT, IL-6, IL-8, TNF-α, and RHI.
  • MPV, PCT, IL-8, and TNF-α were identified as risk factors for vascular endothelial dysfunction.

Conclusions:

  • Platelet and inflammatory factor activation are closely associated with vascular endothelial injury in hypertension.
  • These activated markers serve as valuable indicators of endothelial dysfunction in hypertensive individuals.
  • The findings suggest potential therapeutic targets for mitigating vascular damage in hypertension.
Abstract

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
35
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Inflammation01:38

Inflammation

Overview
54.4K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.6K